Cardiac diseases in AIDS prevention

Statins and aspirin have shown to reduce mortality from CVD in general population, but their use in HIV infected population is uncertain.

• Various studies showed reduced mortality from CVD in HIV infected patients, but this effect was not found to be statistically significant. Statins are well tolerated in HIV infected populations, except for some side effects like myalgia and myopathies.
• Use of aspirin has certainly reduced mortality in general population, but its use in HIV infected patients has not been implicated. Results from CVD prevention trials in HIV infected patients are needed.

Template:WikiDoc Sources CME Category::Cardiology